Summary: Duloxetine is a balanced selective serotonin and norepinephrine-reuptake inhibitor available in the United States for the treatment of major depressive disorder (MDD) and diabetic ...

In patients receiving serotonergic medications in combination with an MAOI, there have been reports of serious and sometimes fatal reactions, including hyperthermia, rigidity, myoclonus, autonomic ...

the first selective serotonin reuptake inhibitor (SSRI). Selective norepinephrine reuptake inhibitors (SNRIs) and new SSRIs followed shortly thereafter. “These drugs were undoubtedly important ...

Axsome Therapeutics, Inc.’s AXSM share price has dipped by 8.23%, which has investors questioning if this is right time to ...

Citalopram, a selective serotonin reuptake inhibitor ... In one trial, women treated unsuccessfully with the serotonin–norepinephrine reuptake inhibitor venlafaxine, were crossed over to ...

AXS-12 (reboxetine), a highly selective and potent norepinephrine reuptake inhibitor and cortical dopamine modulator, which has completed Phase III trial to treat narcolepsy; AXS-14 (esreboxetine ...

However, at times when their depression and anxiety cannot be treated with those, it may be the time to switch to serotonin-norepinephrine reuptake inhibitor (SNRI). This is a common strategy that ...